Côd QR

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transthyretin amyloid cardiomyopathy can be either age-r...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Dulce Brito (Chair), Fabiano Castro Albrecht, Diego Perez de Arenaza, Nicole Bart, Nathan Better, Isabel Carvajal-Juarez, Isabel Conceição, Thibaud Damy, Sharmila Dorbala, Jean-Christophe Fidalgo, Pablo Garcia-Pavia, Junbo Ge, Julian D. Gillmore, Jacek Grzybowski, Laura Obici, Daniel Piñero, Claudio Rapezzi, Mitsuharu Ueda, Fausto J. Pinto
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Ubiquity Press 2023-10-01
Cyfres:Global Heart
Pynciau:
heart failure
amyloidosis
transthyretin amyloid cardiomyopathy (attr-cm)
diagnosis
treatment
patients’ perspective
Mynediad Ar-lein:https://account.globalheartjournal.com/index.php/up-j-gh/article/view/1262
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg